Similarly Dismal Outcomes of AML After an Antecedent Hematologic Disorder and Therapy Related AML

Lalayanni, C; Gavriilaki, E; Athanasiadou, A; Iskas, M; Papathanasiou, M; Marvaki, A; Mpesikli, S; Papaioannou, G; Mallouri, D; Batsis, I; Papalexandri, A; Sakellari, I; Anagnostopoulos, A

Gavriilaki, E (通讯作者),G Papanikolaou Hosp, Hematol Dept, BMT Unit, Thessaloniki 57010, Greece.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022; 22 (4): E233

Abstract

Therapy related acute myeloid leukemia (tAML) and secondary AML after an antecedent hematologic disorder (sAML-AHD) are often addressed together, blur......

Full Text Link